The ‘Hadassah Aids Center’ is setting up a demonstration project in a large clinic in Addis Ababa where prevalence of aids is extremely high. Ethiopia is the third largest country in terms of aids-infected population. 10% of the 60 million are infected, the majority with HIV Type ‘A’.

The project will introduce Aids medicines to a large controlled aids-infected population who will receive its medical treatment in that clinic. It will also involve staff education and training in all aspects required to achieve the project goals.

This project is run as a collaborative effort by the Hadassah Aids Center in Jerusalem with a team of Ethiopian physicians in Addis Ababa. As a vaccine trial site in an area infected with HIV type ‘A’ it will be of much importance in the fight against the most infectious type of HIV. This type of Aids is also found in South Africa, East Africa, China and India.

The project is being submitted for evaluation by the Hadassah Aids Center to The Bill & Melinda Gates Foundation.
This Ethiopian-Israeli Medical Research Project (EIMRP) was seed funded by the Israeli Foreign Ministry, but now wishes to receive funding from a series of new donors.